1 / 4

Autoinjectors Market ppt

Autoinjectors Market

Oliver95
Download Presentation

Autoinjectors Market ppt

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Autoinjectors market share, size and future opportunity till end of 2030

  2. The 2022 global size for autoinjectors market reached USD 64.77 billion and is projected to demonstrate a rapid revenue compound annual growth rate (CAGR) of 17.9% throughout the forecast period. Key drivers of this market growth include the increasing prevalence of targeted therapies, a rising incidence of anaphylaxis, a growing consumer preference for self-administration of drugs, and the enhanced availability of generic autoinjectors. Autoinjectors are medical devices that enable users to self-administer medication either intramuscularly or subcutaneously. They offer several advantages, housing cartridges or pre-filled syringes that operate through a spring mechanism. Their benefits encompass ease of self-administration, improved patient compliance, reduced anxiety levels, and precise dosing. Autoinjectors enable immediate initiation of treatment for both emergency situations such as allergies, migraines, and status epilepticus, and for chronic conditions like diabetes, rheumatoid arthritis, multiple sclerosis, and psoriasis. The increased utilization of autoinjectors is attributed to factors such as the reformulation of first-generation biologics, technological advancements, innovative designs, patient compliance, and the growing necessity for self-administration. To get sample pdf @ https://www.Reportsanddata.Com/download-free-sample/4848

  3. Top companies: B. Braun SE, abbvieinc. Mylan N.V, elililly and company, ypsomed, amgeninc., BD, GSK plc, johnson & johnson services, inc., And antares pharma. Some key highlights from the report Rising prevalence of chronic diseases: the increasing incidence of chronic diseases such as rheumatoid arthritis, multiple sclerosis, diabetes, anaphylaxis, and various autoimmune diseases has boosted the demand for self-injectable drug delivery systems like autoinjectors. Patient preference for self-administration: patients prefer self-administration of medications due to its convenience, reduced healthcare costs, and the ability to manage their conditions in a more personalized manner. Autoinjectors provide an easy-to-use and efficient means for self-administration. Technological advancements: ongoing advancements in autoinjector technology have improved usability, safety features, and user-friendliness, making these devices more widely accepted among patients. The development of smart autoinjectors with connectivity features for monitoring and tracking dosages has also contributed to market growth. Read full report @https://www.Reportsanddata.Com/report-detail/autoinjectors-market

  4. THANK YOU!!

More Related